A new treatment tested in brain organoids with glioblastoma outperformed chemotherapy and dramatically reduced tumors in mice. Human trials are upcoming. The approach also explores stem cell stimulation and aging cell rejuvenation for broader immunotherapy applications.
Study Overview
The toolkit reprograms cells to enhance immune targeting of cancer, showing efficacy in preclinical models without traditional treatments.
Expansion Plans
Testing will extend to other tumor types, including potential pediatric applications.